Skip to content

Sacral Neuromodulation Remote Programming in Patients with Refractory Lower Urinary Tract Dysfunction: China's Experience During the Coronavirus Disease 2019 Pandemic

Sacral Neuromodulation Remote Programming in Patients with Refractory Lower Urinary Tract Dysfunction: China's Experience During the Coronavirus Disease 2019 Pandemic

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057270
Enrollment
Unknown
Registered
2022-03-05
Start date
2022-04-01
Completion date
Unknown
Last updated
2023-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Lower Urinary Tract Dysfunction

Interventions

Group 1 :Remote Programming
Group 2:Routine Programming

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Over 18 years of age; 2. Patients with refractory lower urinary tract dysfunction, such as overactive bladder, neurogenic bladder, interstitial cystitis/chronic pelvic pain, non-obstructive urinary retention, etc.; 3. After entering the group, they agreed not to increase or decrease the related drugs that affect the lower urinary tract symptoms and pelvic function during the study period; 4. Volunteer to participate in the project research and sign the informed consent form; 5. Be able to communicate well with researchers and be willing to comply with the requirements of the whole study.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Complicated with uncontrolled urinary tract infection, urinary tract obstruction and urinary system tumor; 3. Patients with mental illness who cannot cooperate with doctors; 4. There are concomitant diseases that seriously affect health, such as malignant tumors of non urinary system; 5. Other circumstances that the researcher considers inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
voiding diary;

Secondary

MeasureTime frame
Visual analogue scale;Overactive bladder symptom score (OABSS);O’leary-sant Scale;Self designed questionnaire;

Countries

China

Contacts

Public ContactLingfeng Meng

Beijing Hospital

menglfdzs@163.com+86 18518512987

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026